Augsornworawat receives award for research on single-cell sequencing of stem cell-derived islets

On May 2, Punn Augsornworawat, PhD received the Biomedical Engineering Outstanding Research Award for his work in the single-cell sequencing of stem cell-derived islets for diabetes cell therapy.  Augsornworawat joined the Millman Lab back in 2018 as a doctoral student in the Biomedical Engineering PhD program. His interests lie in using bioinformatics to study islet development […]

Millman publishes research on insulin-producing SC-islets after transplantation

On March 16, Jeffrey R. Millman, PhD and collaborators had their research titled “Differential Function and Maturation of Human Stem Cell-Derived Islets After Transplantation,” published in issue 3 of “Stem Cells Translational Medicine.”  It is evident that cell replacement therapy is a potential treatment for patients with diabetes. One possible renewable source of replacement cells are stem-cell […]

McKee discusses strategies for personalized type 2 diabetes treatment

On April 1, ReachMD released an interview featuring Alexis McKee, MD in their “Diabetes Discourse” series. The discussion is titled, “Collaborative Goal Setting in Type 2 Diabetes: Tailoring Treatment Plans for Patients.”  In the 10-minute interview, McKee discusses communication strategies that can be used to create personalized treatment plans and to improve adherence among patients […]

Carmichael publishes article on GLP-1 Receptor Agonists

Kim A. Carmichael, MD published a recent article in the February 2022 issue of Consultant 360 titled, “What Do You Need to Know About GLP-1 Receptors Agonists?”  GLP-1 agonists, otherwise known as glucagon-like peptide 1 agonists, are an important class of medications for patients diagnosed with type 2 diabetes.  As the author and series editor, […]